Imūndeficīta terminālā stāvokļa attīstības riska noteikšanas paņēmiens ar HIV inficētiem pacientiem

Jeļena Eglīte (Inventor), Vladislavs Jasinskis (Inventor), Gunta Stūre (Inventor), Diāna Kasjko (Inventor), Ludmila Vīksna (Inventor), artūrs sočņevs (Inventor)

Research output: Intellectual propertyPatent

Abstract

Invention relates to medicine, particularly to molecular genetics and infection
diseases, may be used in the discovery of human genome mutation to determine the risk of the development of the state of the immunodeficiency in HIV infected patients. The method, wherein to determine the said risk dots mutation, in particular, second exon dot mutation in codon 9, 11, 13, 28, 30, 38, 47, and 82, in the second exon of the HLA‑DRB1*01:01 gene are established, is introduced.
Translated title of the contributionImūndeficīta terminālā stāvokļa attīstības riska noteikšanas paņēmiens ar HIV inficētiem pacientiem
Original languageLatvian
Patent number14901
IPCG01N33/50
Priority date29/04/14
Filing date29/04/14
Publication statusPublished - 20 Feb 2015

Keywords*

  • risk of the terminal state of the immunodeficiency
  • HIV-infected patients

Field of Science*

  • 3.2 Clinical medicine

Patent expiration date

  • 01.11.2021

Fingerprint

Dive into the research topics of 'Imūndeficīta terminālā stāvokļa attīstības riska noteikšanas paņēmiens ar HIV inficētiem pacientiem'. Together they form a unique fingerprint.

Cite this